ROX Financial LP, or ROX LP, is a newly organized Delaware series limited partnership that has been formed to expand access to differentiated commercial real estate investment opportunities intended to be listed on NYSE Arca, Inc., or NYSE Arca. Our platform was built specifically to leverage the economies of scale enabled by our innovative Series […]

Xponential Fitness is a curator of leading boutique fitness brands across multiple verticals. Our mission is to make highly specialized workouts in motivating, community-based environments accessible to everyone. We are the largest boutique fitness franchisor in the United States with over 1,750 studios operating across nine distinct brands. Our diversified portfolio of brands spans a […]

We are a late clinical stage biopharmaceutical company focused on helping patients fight cancer with oncolytic viral immunotherapies. Our engineered viruses are designed to induce immunogenic death through direct viral-mediated cytotoxicity in cancer cells, thus releasing tumor neo-antigens and creating a pro-inflammatory microenvironment at the site of injection. Our approach combines an in-depth knowledge of viral immunotherapy with extensive clinical experience […]

(Note: Ocean Biomedical withdrew its IPO plans in an SEC filing dated Feb. 16, 2023. The clinical biotech announced Feb. 15, 2023, that it had gone public by completing its initial business combination with a SPAC.) We are a biopharmaceutical company that seeks to bridge the “bench-to-bedside” gap between medical research discoveries and patient solutions. We do […]

Founded in 2006, Outbrain pioneered the online content recommendation category. Today our platform enables over 7,000 online properties, including many of the world’s most prestigious publications, helping them engage their users and monetize their visits. We have delivered over $3 billion in direct revenue to our media partners since inception. Some key media partners include Asahi […]

(Note: Elicio Therapeutics, Inc. withdrew its IPO plans in an SEC filing dated Sept. 13, 2022. The IPO was postponed in late July 2021. Elicio Therapeutics filed its S-1 in June 2021.)  We are a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. For therapies designed […]

We are an early-stage bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder (“ADHD”) and Autism Spectrum Disorder (“ASD”). (Incorporated in the Cayman Islands) Our goal is to improve the lives of ADHD and ASD patients, their […]

We will focus our search on a target with operations or prospective operations in the consumer technology, communications, software, SaaS, fintech or media sectors, which we refer to as the “new economy sectors”. In addition, we are focusing our search for target businesses in the following key verticals: Ecommerce, Fintech, SaaS (Software as a Service), […]

We intend to focus our search for a target business in the technology sector. (Bilander Acquisition is a new blank-check company or SPAC incorporated in Delaware.) True Wind Capital, a technology-focused private investment firm, is our advisory platform. Our chairman, Mr. James H. Greene, Jr., is a founding partner of True Wind Capital. We intend […]

We are a leading specialized distributor of water, wastewater, storm drainage and fire protection products, and related services, to municipalities, private water companies and professional contractors across municipal, non-residential and residential end markets nationwide. Our specialty products and services are used in the maintenance, repair, replacement and construction of water and fire protection infrastructure. We are one […]